Product Information

POTASSIUM CITRATE ER 5 MEQ TAB is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.1145 per EA under NDC 00245007011. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Aug 30, 1985. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CITRATE ER 5 MEQ TAB

potassium citrate
$0.1145per EA

Strength

5 meq/1

NDC

00245007011

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

POTASSIUM CITRATE

Approval Type

New Drug (NDA)

FDA Application

NDA019071

FDA Approved

8/30/1985

TE Code

AB

On Market Since

9/1/2006

Pharmacological Classes

Acidifying Activity
Anti-coagulant
Calcium Chelating Activity
Calculi Dissolution Agent
Decreased Coagulation Factor Activity

Price Statistics

The NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 82.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1145 per EA
All-time high$0.9672 (Nov 15, 2017)
All-time low$0.1064 (May 22, 2024)
52-week high$0.1419
52-week low$0.1145
Median price$0.6116
Average price$0.5587
Largest weekly change+79.1% (Jan 18, 2023)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-7.2%

3M

-19.3%

6M

-6.8%

1Y

-8.5%

3Y

-60.4%

5Y

-81.3%

All

-82.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the potassium citrate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of POTASSIUM CITRATE ER 5 MEQ TAB?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 5 MEQ TAB, manufactured by Upsher-Smith Laboratories LLC, is $0.1145 per EA (NDC 00245007011), effective Nov 11, 2026.

How has the price of POTASSIUM CITRATE ER 5 MEQ TAB changed over time?

Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has declined 82.3%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 5 MEQ TAB?

Since Nov 28, 2013, the NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has ranged from a low of $0.1064 (May 22, 2024) to a high of $0.9672 (Nov 15, 2017), with a median of $0.6116 per EA.

Are there cheaper alternatives to POTASSIUM CITRATE ER 5 MEQ TAB?

No other NADAC-published product currently shares the active ingredient and strength of POTASSIUM CITRATE ER 5 MEQ TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures POTASSIUM CITRATE ER 5 MEQ TAB?

POTASSIUM CITRATE ER 5 MEQ TAB (NDC 00245007011) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.